An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

December 10, 2015

Primary Completion Date

November 17, 2016

Study Completion Date

January 17, 2017

Conditions
Dermatitis, Atopic
Interventions
DRUG

Diflucortolone valerate (Nerisona)

Potency Class II (classified as Very Strong class in Japan) topical corticosteroids

DRUG

Diflucortolone valerate (Texmeten)

Potency Class II (classified as Very Strong class in Japan) topical corticosteroids

Trial Locations (1)

514-8507

Tsu

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY

NCT02627989 - An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids | Biotech Hunter | Biotech Hunter